Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)

NCT04433858 is registered in ClinicalTrials.gov with Sheppard Pratt Health System as lead sponsor.

NCT NCT04433858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04433858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Lead sponsor
Sheppard Pratt Health System
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 1, 2021
Completion date
May 1, 2026
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression